InvestorsHub Logo
icon url

tcm55

09/30/20 1:24 PM

#11696 RE: McMagyar #11695

We were ahead of the pack back in May. That Data could have made this but Novotec/SK 1/2 stepped/failed us. We are in a pack now and Data is even more important as some have a 20% benefit. We now need 40%+ to separate us back to the top and be included in a cocktail. Still have confidence in the science, just need some early Data and management to give us some more meat. Fantastic news about accelerated enrollments...GLTA...


BTW
FU Dr Sik ,SK.

https://www.biospectrumasia.com/news/91/15885/algernon-re-purposes-ifenprodil-drug-against-covid-19.html